Inventor · disambiguated record
Mouhannad Jumaa
Also filed as: JUMAA MOUHANNAD
2 granted patents·11 pending applications·16 citations·filing 2004–2023
57Inventor score
Files withONYX THERAPEUTICS INC3BIOPHARMX INC2JUMAA WEINACHT HASSAN2LEWIS EVAN2PERCEPTION NEUROSCIENCE INC2
Top patents by PatentIndex Score
13 records- 0188US10159746B2Cyclodextrin complexation methods for formulating peptide proteasome inhibitorsONYX THERAPEUTICS INC·Filed 2013·Granted Dec 25, 2018·14 cites·30 claims
- 0267US9295708B2Modified release formulations for oprozomibONYX THERAPEUTICS INC·Filed 2013·Granted Mar 29, 2016·2 cites·6 claims
- 0361US2008039533A1Bioactive Compositions Comprising Triazines3M INNOVATIVE PROPERTIES CO·Filed 2004·Application pending·0 cites
- 0456US2024082425A1Lipid structures and compositions comprising sameTURN BIOTECHNOLOGIES INC·Filed 2023·Application pending·0 cites
- 0554US2025195412A1Pharmaceutical formulations of r-ketaminePERCEPTION NEUROSCIENCE INC·Filed 2023·Application pending·0 cites
- 0652US2024336556A1R-ketamine salts and methods of use thereofPERCEPTION NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
- 0747US2019255078A1Topical compositions with stable solubilized selective retinoids and/or tetracycline-class antibioticsBIOPHARMX INC·Filed 2019·Application pending·0 cites
- 0844US2021324092A1Monoclonal antibody composition for treatment of philadelphia chromosome positive acute lymphoblastic leukemiaJUMAA WEINACHT HASSAN·Filed 2021·Application pending·0 cites
- 0943US2023183333A1Composition for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemiaJUMAA WEINACHT HASSAN·Filed 2021·Application pending·0 cites
- 1043US2020129495A1Ebastine topical compositionBIOPHARMX INC·Filed 2018·Application pending·0 cites
- 1141US2013303482A1Cylodextrin Complexation Methods for Formulating Peptide Proteasome InhibitorsLEWIS EVAN·Filed 2012·Application pending·0 cites
- 1241US2013303465A1Cylodextrin Complexation Methods for Formulating Peptide Proteasome InhibitorsLEWIS EVAN·Filed 2012·Application pending·0 cites
- 1337US2016213610A1Modified release formulations for oprozomibONYX THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mouhannad Jumaa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →